JaspreetSinghGrewalMDPhD

Oncology • Louisville, KY

Physician

Join to view full profile

Dr. Grewal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Grewal's full profile

Already have an account?

Office
315 E Broadway
Louisville, KY 40202
Phone+1 502-629-3114

Fax+1 502-629-2443
Is this information wrong?

Education & Training

University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2012 - 2015
St Joseph Mercy Ann ArborResidency, Internal Medicine, 2005 - 2008
Christian Medical College LudhianaClass of 2002
University of Illinois at ChicagoMPH
Michigan State UniversityMS
University of LouisvillePhD

Certifications & Licensure

IN State Medical License 2018 - 2025
KY State Medical License 2012 - 2025
ME State Medical License 2018 - 2019
MA State Medical License 2017 - 2018
MI State Medical License 2005 - 2015
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2021 Aug 09
Recruiting
Phase 1, Phase 2
Roles: Contact
The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors Start of enrollment: 2021 Feb 25
Recruiting
Phase 1
Roles: Principal Investigator

Publications & Presentations

PubMed

2 citations
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma.
Guru P Sonpavde, Benjamin Louis Maughan, Bradley Alexander McGregor, Xiao X Wei, Kerry L Kilbridge, Richard J Lee, Evan Y Yu, Michael Thomas Schweizer, Robert B Montgo...> ;Cancer Immunology, Immunotherapy. 2023 Mar 1
274 citations
Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial.
Mary L. Disis, Matthew H. Taylor, Karen Kelly, J. Thaddeus Beck, Michael S. Gordon, Kathleen M. Moore, Manish R. Patel, Jorge Chaves, Haeseong Park, Alain C. Mita, Eri...> ;JAMA Oncology. 2019 Mar 1
10 citations
Methotrexate-associated primary cutaneous CD30-positive cutaneous T-cell lymphoproliferative disorder: a case illustration and a brief review.
Wederson M. Claudino, Bradley Gibson, William Tse, Maxwell M. Krem, Jaspreet Singh Grewal> ;American Journal of Blood Research. 2016 May 18
21 citations
Bing-Neel Syndrome: A Case Report and Systematic Review of Clinical Manifestations, Diagnosis, and Treatment Options
Jaspreet S. Grewal, Preetkanwal K. Brar, Walter M. Sahijdak, Joseph A. Tworek, Elaine G. Chottiner> ;Clinical Lymphoma & Myeloma. 2009 Dec 1
26 citations
Rapidly progressive metastatic multicentric epithelioid angiosarcoma of the small bowel: a case report and a review of literature
Jaspreet S. Grewal, Amudha R. M. Daniel, Erik J. Carson, Andrew T. Catanzaro, Thomas M. Shehab, Joseph A. Tworek> ;International Journal of Colorectal Disease. 2008 Aug 1
30 citations
Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature
Jaspreet S. Grewal, Lauren B. Smith, Jerome D. Winegarden, John C. Krauss, Joseph A. Tworek, Bertram Schnitzer> ;Annals of Hematology. 2007 Mar 30
Join now to see all

Press Mentions

Knowde Group Inc.™ Enters into a Strategic Partnership with LMC Manna Research to Drive Quality and Collaboration in the Conduct of Cannabis and Psychedelic Clinical TrialsJuly 19th, 2021